April 2024. Reviews plans' priorities in specialty drug cost containment for 2024 and examines activities in utilization management, medical benefit management, formulary and benefit design, and specialty pharmacy network optimization. Reviews the status of biosimilars uptake. Provides market access dashboards and management trends across 12 specialty therapeutic areas.